This Project will use genetically-modified mice to study the overall hypothesis that cardiac K plus channels are expressed in a cell-specific fashion, and that this expression has important functional consequences. Two K plus channel genes are proposed for study: minK and Kv1.5, whose expression is thought to result in Iks and Ikur respectively. Program investigators have generated a mouse in which the minK gene has been removed, and replaced by a reporter (lacZ) whose expression is therefore driven by minK regulatory elements. Preliminary studies in the knockout indicate that, unexpectedly, expression of minK is highly restricted in the adult mouse heart, to the conducting system.
Specific Aim 1 of this Project will determine the functional consequences of deletion of the minK gene. These studies will test not only the hypothesis that minK expression is required to recapitulate native Iks, but also related hypotheses such as whether expression is similarly restricted in other animals, and whether the electrophysiologic effects of deleting minK extend to altered expression or function of other cardiac ion channels. In the second Specific Aim, DNA regulatory elements responsible for restricted expression of minK to the conducting system will be identified using transgenic approaches. In the third Specific Aim, the gene structure of Kv1.5 will be modified by adding a new pharmacologic signature and an epitope tag. Mice carrying the modified gene will then be generated to test the hypothesis that Kv1.5 expression is similarly regionally determined, and to evaluate the resultant functional consequences. These new approached to studying cellular localization and function of ion channels should provide important new information on the mechanisms underlying the heterogeneous electrophysiologic behavior of the heart, the overall goal of this Program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL046681-06
Application #
6242135
Study Section
Project Start
1997-08-01
Project End
1998-07-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Yang, Tao; Smith, Jarrod A; Leake, Brenda F et al. (2013) An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1. Mol Pharmacol 83:481-9
Hayashi, Kenshi; Shuai, Wen; Sakamoto, Yuichiro et al. (2010) Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Heart Rhythm 7:973-80
Yang, Tao; McBride, Brian F; Leake, Brenda F et al. (2010) Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. Br J Pharmacol 161:1023-33
Potet, Franck; Petersen, Christina I; Boutaud, Olivier et al. (2009) Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator. J Mol Cell Cardiol 46:257-67
Yang, Tao; Kanki, Hideaki; Zhang, Wei et al. (2009) Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylation. Br J Pharmacol 157:952-61
Stepanovic, Svetlana Z; Potet, Franck; Petersen, Christina I et al. (2009) The evolutionarily conserved residue A653 plays a key role in HERG channel closing. J Physiol 587:2555-66
Yang, Tao; Chung, Seo-Kyung; Zhang, Wei et al. (2009) Biophysical properties of 9 KCNQ1 mutations associated with long-QT syndrome. Circ Arrhythm Electrophysiol 2:417-26
Grueter, Chad E; Abiria, Sunday A; Wu, Yunji et al. (2008) Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits. Biochemistry 47:1760-7
Baudenbacher, Franz; Schober, Tilmann; Pinto, Jose Renato et al. (2008) Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest 118:3893-903
Makita, Naomasa; Behr, Elijah; Shimizu, Wataru et al. (2008) The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 118:2219-29

Showing the most recent 10 out of 171 publications